Search
Aspiration Pneumonitis
go.drugbank.com/conditions/DBCOND0075845Drugs: Cortisone acetate · Dexamethasone · Hydrocortisone · Methylprednisolone · Prednisolone · PrednisoneSynonyms: Pneumonitis due to inhalation of food and vomitSodium Depletion
go.drugbank.com/conditions/DBCOND0093130Drugs: Sodium chlorideSynonyms: Hypo-osmolality and hyponatremiaWiskott-Aldrich Syndrome (WAS)
go.drugbank.com/conditions/DBCOND0042107Drugs: Etuvetidigene AutotemcelSynonyms: Immunodeficiency with thrombocytopenia AND eczemaAlimentary Obesity
go.drugbank.com/conditions/DBCOND0061821Synonyms: Alteration in nutrition: more than body requirements (finding)Fetal Status, Nonreassuring
go.drugbank.com/conditions/DBCOND0155307Drugs: RitodrineSynonyms: (Fetal distress) or (meconium in liquor)Quazepam
go.drugbank.com/drugs/DB01589ApprovedIllicitQuazepam is a trifluoroethyl benzodiazepine derivative. It was first approved in the US in 1985 and is used as a hypnotic for the treatment of insomnia. … [L44913] It appears to be unique amongst other benzodiazepine derivatives in its relatively high affinity for sleep-promoting α1 subunit-containing GABA<sub>A</sub> receptors and low affinity for other
Categories: Hypnotics and Sedatives, Benzodiazepine hypnotics and sedativesGliclazide
go.drugbank.com/drugs/DB01120ApprovedInvestigationalGliclazide is extensively metabolized by the liver; its metabolites are excreted in both urine (60-70%) and feces (10-20%). … Gliclazide is an oral antihyperglycemic agent used for the treatment of non-insulin-dependent diabetes mellitus (NIDDM).
Categories: Drugs Used in Diabetes, Alimentary Tract and MetabolismProducts: Gliavis IR Tablet 80mg, Rolazide Tablet 80mgFenoldopam
go.drugbank.com/drugs/DB00800ApprovedA dopamine D1 receptor agonist that is used as an antihypertensive agent. It lowers blood pressure through arteriolar vasodilation.
Categories: Adrenergic and Dopaminergic AgentsET140203
go.drugbank.com/drugs/DB17196InvestigationalSynonyms: an autologous T-cell immunotherapy (ET140203)Cangrelor
go.drugbank.com/drugs/DB06441ApprovedInvestigationalCangrelor was approved by the FDA in June 2015 for intravenous application. … Cangrelor is an intravenous, direct-acting, reversible P2Y12 inhibitor for patients undergoing percutaneous coronary intervention (PCI) who have not been yet treated by oral P2Y12 inhibitors.
Categories: Blood and Blood Forming Organs, Nucleic Acids, Nucleotides, and Nucleosides